Optimizing osteoporosis treatment outcomes: shared-decision making and adherence support program

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON22858

Enrollment

210

Registered

2018-08-17

Start date

2018-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

The study entails a 1-year trial to assess the (cost-) effectiveness of a multi-component adherence intervention (MCAI) combining a patient DA, a nurse-led adherence support program and one extra FLS

Eligibility

Inclusion criteria

Inclusion criteria: I) Recent fracture II) Diagnosed with Osteoporosis (confirmed with dual-energy x-ray absorptiometry (DXA)) III) Eligable for anti-osteoporosis treatment IV) Not used anti-osteoporosis medication in the last 12 months V) Age higher than 50 years when included.

Exclusion criteria

Exclusion criteria: I) Beeing treated for malignancies. II) Incapable to comprehend the treatment and the study.

Design outcomes

Primary

Measure	Time frame
I) The effect of the MCAI on medication persistence. II) The estimated lifetime cost-effectiveness of the MCAI compared to usual care for healthcare and societal perspective.	—

Secondary

Measure	Time frame
Secondary outcomes include: decision quality, medication initiation, alternative measures of adherence, health status (fracture events and mortality), quality of life and societal costs.	—

Contacts

Public ContactDennis Cornelissen

Maastricht University

d.cornelissen@maastrichtuniversity.nl+31 (0)43 38781551

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)